U.S. Aerovate Therapeutics, Boeing, Wingstop
June 18 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday.
HIGHLIGHTS
* Aerovate Therapeutics Inc AVTE.O: TD Cowen cuts to hold from buy |
* Boeing BA.N: RBC cuts target price to $210 from $215 |
* Mirum Pharmaceuticals Inc MIRM.O: Evercore ISI raises target price to $62 from $53 |
* Transdigm Group Inc TDG.N: RBC raises target price to $1,500 from $1,400 |
* Wingstop Inc WING.O: Stifel raises target price to $460 from $420 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Aaron's Company Inc AAN.N: Truist Securities raises target price to $10.10 from $8 |
* Abbvie Inc ABBV.N: Piper Sandler raises target price to $190 from $185 |
* Addus Homecare Corp ADUS.O: TD Cowen raises target price to $128 from $119 |
* Aerovate Therapeutics Inc AVTE.O: Guggenheim cuts to neutral |
* Aerovate Therapeutics Inc AVTE.O: TD Cowen cuts to hold from buy |
* Apple Inc AAPL.O: JP Morgan raises target price to $245 from $225 |
* Arhaus Inc ARHS.O: Jefferies raises target price to $22 from $19 |
* Beyond Inc BYON.N: BofA Global Research cuts price objective to $15.5 from $19 |
* Beyond Inc BYON.N: Jefferies cuts target price to $15 from $18 |
* Boeing BA.N: RBC cuts target price to $210 from $215 |
* Cardlytics CDLX.O: Northland Capital initiates coverage with outperform rating; PT $14 |
* Carmax Inc KMX.N: Mizuho cuts target price to $72 from $75 |
* Carmax Inc KMX.N: Truist Securities cuts target price to $66 from $72 |
* Casella Waste Systems Inc CWST.O: Stifel raises target price to $110 from $105 |
* Celldex Therapeutics CLDX.O: Stifel initiates coverage with buy rating; PT $58 |
* Chegg Inc CHGG.N: Jefferies cuts target price to $2.50 from $4 |
* Chegg Inc CHGG.N: Northland Capital cuts target price to $7 from $10 |
* Chipotle Mexican Grill CMG.N: Argus Research raises PT to $3,888 from $3,668 |
* Chromocell Therapeutics CHRO.A: Alliance Global Partners initiates coverage with buy rating; PT $8.50 |
* Clean Harbors Inc CLH.N: Stifel raises target price to $240 from $230 |
* Constellation Energy Corp CEG.O: UBS raises target price to $249 from $227 |
* Corning Inc GLW.N: Mizuho raises target price to $42 from $36 |
* Corteva Inc CTVA.N: Mizuho cuts target price to $60 from $61 |
* Darden Restaurants Inc DRI.N: Deutsche Bank cuts target price to $180 from $183 |
* Digitalbridge Group Inc DBRG.N: Deutsche Bank cuts target price to $17 from $21 |
* Digitalbridge Group Inc DBRG.N: KBW cuts target price to $17.75 from $18.5 |
* Energy Transfer LP ET.N: Mizuho raises target price to $20 from $19 |
* Equitable Holdings Inc EQH.N: UBS cuts to neutral from buy |
* Equitable Holdings Inc EQH.N: UBS raises target price to $43 from $40 |
* Geovax Labs GOVX.O: H.C. Wainwright adjusts PT to $8 to reflect 1-for-15 reverse stock-split |
* Granite Ridge Resources Inc GRNT.N: Gerdes Energy Research initiates with buy rating |
* Granite Ridge Resources Inc GRNT.N: Gerdes Energy Research initiates with PT $7 |
* Humacyte Inc HUMA.O: TD Cowen raises target price to $7.5 from $6 |
* Innoviva Inc INVA.O: Cantor Fitzgerald initiates coverage with overweight rating |
* Intra-Cellular Therapies Inc ITCI.O: RBC raises target price to $103 from $96 |
* Juniper Networks Inc JNPR.N: Argus Research raises to buy from hold |
* Knife River Corp KNF.N: Stephens initiates coverage with overweight rating; PT $85 |
* Kroger Co KR.N: BMO raises target price to $60 from $58 |
* Kroger Co KR.N: BMO raises to outperform from market perform |
* Levi Strauss & Co LEVI.N: TD Cowen raises target price to $26 from $23 |
* Loar Holdings Inc LOAR.N: RBC raises target price to $65 from $60 |
* McCormick & Company Inc MKC.N: Jefferies cuts target price to $73 from $77 |
* Micron Technology Inc MU.O: BofA Global Research adds stock to its U.S. 1 list |
* Micron Technology Inc MU.O: Stifel raises target price to $165 from $140 |
* Micron Technology Inc MU.O: Wedbush raises target price to $170 from $130 |
* Mirum Pharmaceuticals MIRM.O: Citigroup raises target price to $64 from $38 |
* Mirum Pharmaceuticals MIRM.O: Evercore ISI raises target price to $62 from $53 |
* Mirum Pharmaceuticals MIRM.O: JP Morgan raises target price to $39 from $31 |
* Mirum Pharmaceuticals MIRM.O: Morgan Stanley raises target price to $57 from $53 |
* Mirum Pharmaceuticals MIRM.O: Raymond James raises target price to $71 from $60 |
* Montrose Environmental Group Inc MEG.N: Stifel raises target price to $56 from $51 |
* Motorola Solutions Inc MSI.N: Morgan Stanley raises target price to $365 from $335 |
* Nurix Therapeutics Inc NRIX.O: H.C. Wainwright raises target price to $26 from $19 |
* Nvidia Corp NVDA.O: Rosenblatt Securities adjusts price target to $200 to reflect 10-for-1 stock split |
* Nvidia Corp NVDA.O: Wells Fargo raises target price to $155 from $125 |
* Oge Energy Corp OGE.N: Barclays raises target price to $35 from $34 |
* Old Dominion Freight Line Inc ODFL.O: Jefferies cuts target price to $185 from $200 |
* Omega Therapeutics Inc OMGA.O: Raymond James initiates coverage with outperform rating; PT $12 |
* Oracle Corp ORCL.N: Argus Research raises target price to $159 from $145 |
* Ovid Therapeutics Inc OVID.O: BTIG cuts target price to $5 from $11 |
* Ovid Therapeutics Inc OVID.O: Citigroup cuts target price to $1.2 from $3.5 |
* Ovid Therapeutics Inc OVID.O: H.C. Wainwright cuts target price to $3 from $9 |
* Ovid Therapeutics Inc OVID.O: Oppenheimer cuts to perform from outperform |
* Perspective Therapeutics CATX.A: Oppenheimer adjusts target price to $19 from $2 to reflect 1-for-10 reverse stock split |
* Pilgrims Pride PPC.O: Argus Research initiates coverage with buy rating; PT $41 |
* Portillos Inc PTLO.O: Guggenheim cuts target price to $18 from $22 |
* Portillos Inc PTLO.O: Jefferies cuts target price to $18 from $19 |
* Praxis Precision Medicines Inc PRAX.O: Guggenheim initiates coverage With Buy rating; PT $155 |
* Primo Water Corp PRMW.N: CIBC raises target price to $26 from $24 |
* Primo Water Corp PRMW.N: JP Morgan raises target price to $26 from $24 |
* Primo Water Corp PRMW.N: Raymond James raises target price to $26 from $23 |
* Primo Water Corp PRMW.N: TD Cowen raises target price to $32 from $30 |
* Q2 Holdings Inc QTWO.N: Truist Securities raises target price to $68 from $65 |
* Qiagen NV QGEN.N: UBS raises target price to $46 from $44 |
* Quantum Corp QMCO.O: Northland Capital cuts target price to $0.50 |
* Quinstreet Inc QNST.O: Craig-Hallum raises target price to $22 from $20 |
* Quinstreet Inc QNST.O: Craig-Hallum raises to buy from hold |
* RB Global Inc RBA.N: CIBC initiates coverage with outperformer rating; PT $95 |
* Reddit RDDT.N: Needham raises target price to $75 from $63 |
* Repligen Corp RGEN.O: Guggenheim initiates coverage With Neutral rating |
* Republic Services Inc RSG.N: Stifel raises target price to $215 from $210 |
* Silk Road Medical Inc SILK.O: Piper Sandler raises PT to $27.50 from $20 |
* Steel Dynamics Inc STLD.O: BMO cuts target price to $135 from $140 |
* Sunoco LP SUN.N: Citigroup raises to buy from neutral |
* Teradyne Inc TER.O: UBS raises target price to $170 from $130 |
* The Hershey Company HSY.N: Barclays cuts target price to $204 from $210 |
* Third Harmonic Bio Inc THRD.O: Stifel initiates coverage with buy rating; PT $23 |
* Transdigm Group Inc TDG.N: RBC raises target price to $1,500 from $1,400 |
* Triumph Financial Inc TFIN.O: KBW raises target price to $75 from $68 |
* Urban Outfitters Inc URBN.O: Barclays raises target price to $52 from $50 |
* Viasat Inc VSAT.O: Morgan Stanley cuts target price to $26 from $28 |
* Waste Management Inc WM.N: Stifel raises target price to $231 from $227 |
* Williams Companies Inc WMB.N: Truist Securities raises target price to $42 from $40 |
* Wingstop Inc WING.O: Stifel raises target price to $460 from $420 |
* Wolfspeed Inc WOLF.N: Mizuho raises target price to $28 from $27 |
* Xponential Fitness Inc XPOF.N: Guggenheim raises target price to $20 from $18 |
* Zentalis Pharmaceuticals Inc ZNTL.O: H.C. Wainwright cuts target price to $20 from $40 |
* Zentalis Pharmaceuticals Inc ZNTL.O: Wedbush cuts to underperform from neutral |
* Zentalis Pharmaceuticals Inc ZNTL.O: Wedbush cuts target price to $4 from $15 |
(Compiled by Bengaluru Newsroom)
</body></html>免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。